Press release
Hormonal Contraceptives Market Growth Evolution, Trends Innovation, Major Product Segment and Forecasts Report 2031 | Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson ,Ansell LTD.
New York, According to a new market research report published by Global Insight Services Hormonal Contraceptives Market is expected to reach US$ XX bn by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.Hormonal contraceptives are drugs that prevent pregnancy. There are many different types of hormonal contraceptives, including the pill, the patch, the ring, injectables, implants, and emergency contraception.
Read more about Hormonal Contraceptives Market here : https://www.globalinsightservices.com/reports/hormonal-contraceptives-market
Key Trends
The key trends in hormonal contraceptives technology are the development of more effective and longer-lasting products, as well as the development of new delivery methods such as patches, rings, and injections. There has also been a trend towards the development of products that can be used by both men and women.
The most effective hormonal contraceptives available today are intrauterine devices (IUDs), which can provide up to 99% protection against pregnancy. IUDs are long-acting, reversible, and do not require daily compliance. They are also considered to be safe for use by women of all ages, including those who have not yet had children.
The next most effective hormonal contraceptive is the contraceptive implant, which is a small rod that is inserted under the skin of the upper arm. The implant releases a steady stream of the hormone progestin, which prevents ovulation and thickens the mucus in the cervix, making it difficult for sperm to reach the egg. The implant is effective for up to three years and can be removed at any time.
Download a Free PDF Sample Copy of Report : https://www.globalinsightservices.com/request-sample/GIS21881
Key Drivers
The key drivers of the Hormonal Contraceptives market are the rising incidence of unintended pregnancies and the growing awareness of the importance of family planning. The other drivers include the favorable government policies and the availability of a wide range of contraceptive products.
The rising incidence of unintended pregnancies is the major driver of the Hormonal Contraceptives market. The main reasons for the increase in the number of unintended pregnancies are the lack of knowledge about contraception and the lack of access to family planning services.
The other driver of the Hormonal Contraceptives market is the growing awareness of the importance of family planning. This is due to the growing awareness of the importance of family planning among the people. The other reasons for the decline in the total fertility rate are the declining birth rate and the increasing use of contraception.
Market Segments
The Hormonal Contraceptives Market is segmented by product, hormone, age group, and region. By product, the market is divided into oral contraceptive pills, injectable birth control, emergency contraceptive pills, and others. On the basis of hormones, it is divided into progestin-only contraceptive and combined hormonal contraceptive. On the basis of age group, it is divided into 15-24 years, 25-34 years, 35-44 years, and above 44 years. Region-wise the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The Hormonal Contraceptives Market includes players such as The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson ,Ansell LTD., Mayer Laboratories, Merck & Co., Inc.
Get Customized report as per your requirements : https://www.globalinsightservices.com/request-customization/GIS21881
Reasons to buy Hormonal Contraceptives Market Report:
• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hormonal Contraceptives Market Growth Evolution, Trends Innovation, Major Product Segment and Forecasts Report 2031 | Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson ,Ansell LTD. here
News-ID: 2702056 • Views: …
More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…

GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…

Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…

Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Hormonal
United States Endometriosis Treatment Market Report 2025: Pain Medication, Hormo …
The Global Endometriosis Treatment market reached US$ 1.59 billion in 2024 and is expected to reach US$ 3.91 billion by 2033, growing at a CAGR of 10.62% during the forecast period 2025-2033.
The Endometriosis Treatment Market encompasses the range of pharmaceutical drugs, hormonal therapies, surgical interventions, and diagnostic tools used to manage and treat endometriosis a chronic condition where tissue similar to the endometrium grows outside the uterus, causing pain, infertility,…
Contraceptives Market Detailed in New Research Report with Emerging Hormonal and …
Contraceptives Market Insights
Global contraceptive market was valued US$ 19.79 Bn in 2025 and is expected to reach US$ 47.14 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 13.20% from 2025 to 2032.
Coherent Market Insights has released a detailed analysis of the Contraceptives Market (2025-2032), focusing on the evolving U.S. healthcare landscape. The report presents critical metrics such as market size, revenue forecasts, CAGR, adoption patterns, and key…
Hormonal Contraceptives Market - Confidence, Convenience, and Control: Elevating …
Newark, New Castle, USA: The "Hormonal Contraceptives Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hormonal Contraceptives Market: https://www.growthplusreports.com/report/hormonal-contraceptives-market/7790
This latest report researches the industry structure, sales, revenue,…
Non-Hormonal Birth Control Market - Empowering Choice, Embracing Control: Non-Ho …
Newark, New Castle, USA - new report, titled Non-Hormonal Birth Control Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Non-Hormonal Birth Control market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Non-Hormonal Birth Control market. The report offers an overview of…
Hormonal Contraceptives Market Size, Share | Hormonal Contraceptives Industry Fu …
Global Hormonal Contraceptives Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Hormonal Contraceptives Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,…
High Awareness in Female Population Regarding Hormonal Disorders Drives the Pres …
Global Prescription Hormonal Drugs Market in Gynecology: Description
Hormonal imbalance in women is caused due to abnormalities in the secretion of estrogen, progesterone and as well as androgens. A wide array of symptoms might be experienced by patients depending on the type of abnormality such as hot flushes, depression, vaginal dryness, excessive hair growth and abnormal vaginal bleeding. Environmental and genetic factors have an influence on women's fertility through their effect…